This Letter describes the synthesis and SAR of the novel positive allosteric modulator, VU0155041, a compound that has shown in vivo efficacy in rodent models of Parkinson's disease. The synthesis takes advantage of an iterative parallel synthesis approach to rapidly synthesize and evaluate a number of analogs of VU0155041.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752865 | PMC |
http://dx.doi.org/10.1016/j.bmcl.2009.07.072 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!